Lung Transplantation for Scleroderma Lung Disease: Indications, Survival and Prognosis

Due to its multisystemic nature, scleroderma (SSc) remains a relative contraindication to lung transplantation in many transplantation centers. However, recent studies suggest that post-transplant outcomes in patients with SSc do not differ significantly from those in patients with interstitial lung diesase (ILD). However, the impact of SSc-associated pulmonary arterial hypertension (PAH) on post transplant outcome remains unknown. Objective: to investigate demographics, survival and prognostic factors in a multicentric cohort of well-characterized patients with SSc lung disease undergoing lung or heart-lung transplantation.

Source: The Journal of Heart and Lung Transplantation - March 31, 2018 Category: Transplant Surgery Authors: P. Prad ère, I. Tudorache, J. Magnusson, L. Savale, O. Brugière, B. Douvry, M. Reynaud-Gaubert, J. Claustre, A. Le Borgne, A.M. Holm, H.H. Schulz, C. Knoop, L. Godinas, A. Fisher, S. Hirschi, J. Gottlieb, J. Le Pavec Source Type: research